0. Advocacy Graphic






The Voice of Addiction Medicine

 Leading the movement to transform America's addiction treatment infrastructure and expand access to research-validated, results-based care

ASAM's Advocacy Principles

Advocacy Webpage Graphics Teach It
TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma
Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of addiction medicine so that more patients receive high-quality, evidence-based care
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to coordinated, comprehensive care
 
Advocacy Homepage HR 6 Graphic
 




It's time we treat addiction like other chronic diseases 



workshop2

Advocacy Committees & Councils

ASAM's advocacy could not happen if not for the dedicated effort of our members.

0. Find a Policy Statement 1 - cropped

Public Policy Statements

Learn about ASAM's position on current policy issues.

Teamwork - smallest

Coalitions

ASAM is proud to work collaboratively with others to improve the lives of those living with addiction.
0. Advocacy Toolkits

Advocacy Toolkits

ASAM provides toolkits to help you advocate for public policies that advance addiction medicine and promote access to treatment


 
Legislative Tracker Graphic
 



newspapers-3488857_1920B

The Journal of Law, Medicine & Ethics Accepts Letter to the Editor Urging ACGME to Establish Opioid Use Disorder Education Requirement

by | Oct 07, 2019

 

The Journal of Law, Medicine & Ethics recently accepted publication of a letter to the editor titled “In Support of Residency Training to Address the Opioid Overdose Epidemic,” which urges the Accreditation Council for Graduate Medical Education (ACGME) to establish a requirement that all residents and fellows who care for patients who use opioids, as well as their core faculty, receive specific training on the treatment of opioid use disorder (OUD).

 

The letter notes that while the ACGME has significant oversight regarding educating and training physicians, none of its curriculum components require that physicians-in-training receive instruction on the treatment of OUD. Furthermore, physicians themselves have shown a lack of interest in training, with fewer than 7% of American physicians having completed the necessary 8-hour DATA 2000 waiver training to prescribe buprenorphine. Therefore, the letter concludes that in order for physicians to be sufficiently prepared to combat the opioid overdose epidemic, the ACGME must step in and require training in treatment of OUD.

 

Read the letter here

 

If you are interested in adding your name to the letter as a signatory you may do so here.